In the last 10 years, the term "big data" has become a keyword in many different contexts. Despite being a widespread term, though, it is not always clear what it refers to.
Perspectives
Focus on
Thanks to the global access to information on the Internet, patients have become more and more critic and sometimes worried about the potential adverse reactions to drugs. This situation has enhanced the necessity for their doctors and other health professionals to update their knowledge on...
Columns
Drugs & Children
Over the last 20 years, biological drugs have changed the therapeutic prospect for chronic inflammatory bowel diseases both in the adult and in the child.1 Infliximab was the first drug that, when its patent expired, had biosimilars authorised by EMA, CT-P13 and SB2 respectively in 2013 and 2016.2...
From regulatory agencies
| 08 August 2018 FDA | 03 August 2018 FDA |
| 30 July 2018 AIFA | 30 July 2018 AIFA |
| 30 July 2018 AIFA | 27 July 2018 EMA |
| 26 July 2018 AIFA | 25 July 2018 AIFA |
| 20 July 2018 AIFA | 19 July 2018 FDA |